Hypoxic therapy and comorbidity in older adults: a report on quality of life and daily activity. How the authors assessed patients with cardiovascular and coexisting diseases.
A detailed editorial account of the authors’ presentation. It combines a review of mechanisms with clinical observations; the description of group composition is limited. Questionnaire results do not establish life extension. The equipment used in the observation differs from OXYTERRA RS. The original slides are available as a PDF.
Publication at a glance
- The use of normobaric hypoxic therapy in older patients is described.
- Daily activity and quality of life assessed by questionnaires are discussed.
- The slides do not describe the study in enough detail to assess all risks of bias.
Hypoxic therapy and comorbidity in older adults: the report’s aim
T. S. Ignatenko and colleagues consider adaptation-based methods in older patients. Comorbidity means the coexistence of several diseases in one person. The report focuses on cardiovascular disease and its combination with other chronic conditions.
The authors are interested in daily activity as well as individual symptoms. The main clinical question is whether quality of life and the level of everyday exertion patients can manage change. The presentation also provides a general review of proposed mechanisms of hypoxic adaptation.
Participants and selection criteria
The clinical part considered people aged 60–75 years. Inclusion criteria required cardiovascular disease with stage I–II chronic heart failure. Coexisting conditions were COPD and/or type 2 diabetes.
Acute forms of coronary artery disease and acute cerebrovascular events were excluded from the observation. Severe hypertension, COPD exacerbation, marked respiratory failure, and infections are also listed. These criteria matter when applying the results to other patients.
The slides do not provide a comprehensive description of the size and allocation of all groups. The presentation therefore cannot establish how comparable the participants were. This gap should not be filled by assuming randomization.
Course of normobaric hypoxic therapy
The first group received 15 sessions of intermittent normobaric hypoxic therapy. The authors report using the Tibet-4 system. Each session included four series of five-minute hypoxic exposures.
The exposures were separated by five-minute intervals of breathing room air. Thus, the clinical protocol described alternated hypoxia and normoxia. Mention of a hypoxic-hyperoxic generator in the equipment name does not make these breaks hyperoxic.
The report emphasizes a preliminary medical examination and individual tolerance. The authors relate exposure duration to oxygen saturation, pulse, and blood pressure. These details describe the research program and are not instructions for selecting a regimen independently.
Measuring quality of life and activity
The authors used the Minnesota Living with Heart Failure Questionnaire (MLHFQ) to assess quality of life. Daily physical activity was assessed using Duke University’s DASI index. These tools reflect questionnaire measures rather than a direct measurement of lifespan.
Repeat assessments took place three and six months after the study began. The authors compared changes in the first group with baseline values. They also considered subgroups with COPD and type 2 diabetes.
Changes described by the authors
In the first group, MLHFQ quality of life improved after three and six months. The authors characterize changes from baseline as statistically significant. In the COPD subgroup, significance was noted only after six months.
In participants with type 2 diabetes, improvement reached significance after three months. It persisted after six months. DASI daily activity scores also increased in the first group and both subgroups.
In the second group, the authors noted no substantial change in DASI. Thus, the clinical part of the report supports interest in older patients’ daily functioning. The exact graphs and comparisons are presented in the original slides.
Practical outcome and interpretation
The main outcome of the observation was an improvement in questionnaire measures of quality of life and daily activity. This concerns combined treatment of patients with specific combinations of diseases.
The presentation’s general statements about regeneration, stem cells, and reduced medication doses are not results of this observation. They should not be interpreted as proven benefits for every patient. Changes to prescribed medication are made by the treating physician, not by patients themselves after reading the report.
Original publication data
The complete tables, illustrations, and authors’ wording are available in the original PDF. The links below open the corresponding pages of the original.
Inclusion and exclusion criteria
Technology and practice
Feedback and session monitoring are described in the IHHT Technology section.
Learn about IHHT in active longevity and wellness programs in the Applications section.